Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2008
11/18/2008US7452973 modified by substituting negatively charged amino acids with positively charged amino acids on the exterior of the protein making the protein cell permeable; obviates the need for transfections
11/18/2008US7452972 Nucleic acids and proteins showing increased expression dose under salt stress
11/18/2008US7452971 Compositions and methods for modifying toxic effects of proteinaceous compounds
11/18/2008US7452970 G-protein coupled receptors for identifying modulators for prevention and treatment of cardiovascular, urogenital and hypertensive disorders
11/18/2008US7452968 proteins that modulate the growth, differentiation, trafficking and physiology of mammalian cells, e.g., cells of the hematopoietic system and the neuronal system of mammals
11/18/2008US7452967 Caspase recruitment domain (CARD); tumor suppressor genes; oncogenes; antiproliferative agents; antitumor agents; antiinflammatory agents; antiapoptosis
11/18/2008US7452966 GLP-1 analog fusion proteins
11/18/2008US7452963 From 7 to 50 amino acids comprising: (1) a lysine residue six to ten residues from a second lysine residue; (2) a histidine residue; and (3) at least 6% lysine residues
11/18/2008US7452869 For modulating necrosis and treating neurological/ cardiovascular diseases
11/18/2008US7452866 Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit 1
11/18/2008US7452865 Antagonistic analogs of GH RH (2003)
11/18/2008US7452864 chronic ulcers; cytotoxic effect of LL-37 may be reduced by including a bilayer-forming polar lipid, especially a digalactosyldiacylglycerol, in pharmaceutical compositions and growth media
11/18/2008US7452863 NGF variants
11/18/2008US7452859 Having serine protease inhibitory activity
11/18/2008US7452856 partial peptide based upon the amino acid sequences of a guinea-pig-derived antimicrobial polypeptide and partially substituted forms; lipopolysaccharide-cell-binding inhibitor
11/18/2008US7452721 Protein-free medium comprising agent that balances the oncotic pressure across semipermeable cell membranes for use detecting parasitic infection; immunodiagnostics
11/18/2008US7452715 expression of the lipidated form of the peptidoglycan-associated protein (PAL) of gram-negative bacteria is achieved through the use of a plasmid containing a tightly regulated promoter; bacterial host cell transformed, transduced or transfected with the plasmid
11/18/2008US7452709 Method of screening prion disease infection factor
11/18/2008US7452706 Recombinant bacterial phytases and uses thereof
11/18/2008US7452697 Chromatographic method and system for purifying a botulinum toxin
11/18/2008US7452694 Identifying modulators of g-protein coupled receptor associated with taste/flavor transduction; food processing and artificial sweetners
11/18/2008US7452693 Used in antibacterial, immunosuppressant, and antitumor drug making; loading an extender molecule on an acyl carrier protein (ACP) domain
11/18/2008US7452685 Nucleotide sequences coding g-protein coupled receptors for identifying modulators of sweet taste transduction; sweetners and flavoring; tastands and food treatment
11/18/2008US7452684 Collagen XXII, a novel human collagen and uses thereof
11/18/2008US7452682 Identification of 5HT2A receptor ligands by selective amplification of cells transfected with receptors
11/18/2008US7452680 MCT1 transporters expressed in blood brain barrier cells
11/18/2008US7452667 Diagnosis of mild osteoarthritis by determination of TNFAIP6 and TGFBI RNA levels
11/18/2008US7452551 Administering to the patient a contrast agent comprising, in an aqueous carrier, targeted vesicles formulated from a lipid or polymer, a perfluorocarbon gas, a targeting ligand, scanning the patient using ultrasound to obtain an image
11/18/2008US7452544 Bacteriocins and novel bacterial strains
11/18/2008US7452543 Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics
11/18/2008US7452541 Hapten-carrier conjugates and uses thereof
11/18/2008US7452538 Death domain containing receptor 4 antibodies and methods
11/18/2008US7452536 Inhibiting OX-2 (also called CD200) gene expression to treat a tumor that is associated with increased CD200 expression; leukemia; phage display screening for antigens; monoclonal antibodies; fusion proteins; use of OX-2 preventing graft rejection, autoimmune disease, and in inducing tumor cell growth
11/18/2008US7452535 Methods of treatment using CTLA-4 antibodies
11/18/2008CA2440399C Epitope testing using hla
11/18/2008CA2437201C Methods and compositions useful for stimulating an immune response
11/18/2008CA2394984C Novel plant expression constructs
11/18/2008CA2381219C Monomeric protein of the tgf-beta family
11/18/2008CA2330837C A vector expressing an rna viral full-length gene and its use
11/18/2008CA2313515C A process for preparing a kappa-caseino glycomacropeptide or a derivative thereof
11/18/2008CA2288234C Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
11/18/2008CA2281614C Monomers derived from hydroxy acids and polymers prepared therefrom
11/18/2008CA2265444C Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods
11/18/2008CA2241941C Therapeutic agent containing .omega.-feline interferon for treating feline aids virus infections and feline atopic dermatitis
11/18/2008CA2221517C Synthesis of n-substituted oligomers
11/18/2008CA2210491C Antagonists of interleukin-15
11/18/2008CA2193993C New hil-4 mutant proteins used as antagonists or partial agonists of human interleukin 4
11/18/2008CA2184635C Combined use of genetic markers for the diagnosis of alzheimer's disease, diagnostic kit and method
11/18/2008CA2157975C Recombinant mersacidin and a method for production
11/18/2008CA2136230C Clostridium perfringens vaccines
11/18/2008CA2133587C Compounds having selectivity for retinoid x receptors
11/18/2008CA2124329C Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
11/18/2008CA2095421C Novel amyloid precursor proteins and methods of using same
11/18/2008CA1341585C Recombinant retroviruses
11/18/2008CA1341583C Interferons and process for their preparation
11/16/2008CA2681295A1 Novel methods for recovery of leaf proteins
11/13/2008WO2008138001A2 Synthetic peptides and peptide mimetics
11/13/2008WO2008137881A2 Ehrlichia ewingii proteins, nucleic acids, and methods of their use
11/13/2008WO2008137681A2 Pp1 ligands
11/13/2008WO2008137471A2 Modified interferon beta polypeptides and their uses
11/13/2008WO2008137228A1 System and method for local field stimulation
11/13/2008WO2008137108A2 Plants having enhanced yield-related traits and a method for making the same
11/13/2008WO2008137065A1 Methods of raising crustaceans in low salinity water
11/13/2008WO2008136888A2 Second generation low oxygen affinity pegylated hemoglobins as oxygen-carrying plasma expanders
11/13/2008WO2008136736A2 Immunoregulatory structures from normally occurring proteins
11/13/2008WO2008136564A1 A novel ylmpo1 gene derived from yarrowia lipolytica and a process for preparing a glycoprotein not being mannosylphosphorylated by using a mutated yarrowia lipolytica in which ylmpo1 gene is disrupted
11/13/2008WO2008136470A1 Hcv gene
11/13/2008WO2008136345A1 Polypeptide capable of improving tolerance to iron deficiency in plant, and use thereof
11/13/2008WO2008136014A1 Cloning and expression of enterokinase and its process for production
11/13/2008WO2008135972A2 Glycan modified soluble receptors and binding proteins and their use
11/13/2008WO2008135568A1 Chromatography process for obtaining a fviii/vwf complex with different ratios between the two proteins, for use in haemophilia a treatment and in von willebrand disease
11/13/2008WO2008135501A1 Improvement of factor viii polypeptide titers in cell cultures
11/13/2008WO2008135446A2 Klebsiella antigens
11/13/2008WO2008135237A1 Complement factor h-derived short consensus repeat-antibody constructs
11/13/2008WO2008135229A2 Formulation of sugar solutions for continuous ultracentrifugation for virus purification
11/13/2008WO2008135206A2 Means and methods for providing ribulose bisphosphate-carboxylase-oxygenase with improved properties
11/13/2008WO2008135067A1 Method for the diagnosis of tuberculosis
11/13/2008WO2008134935A1 Truncated human papillomavirus type 18 l1 proteins
11/13/2008WO2008134934A1 A truncated l1 protein of human papillomavirus 16
11/13/2008WO2008134879A1 Il-12 immunotherapy for cancer
11/13/2008WO2008134878A1 Compositions and methods for cancer treatment
11/13/2008WO2008115759A3 Compositions and methods for reducing h2s levels in fermented beverages
11/13/2008WO2008115596A3 Over expression of foldases and chaperones improves protein production
11/13/2008WO2008107862A3 Use of ngf for the preparation of medicaments for the cure of reactive gliosis
11/13/2008WO2008105890A8 Chloroplast transit peptides for efficient targeting of dmo and uses thereof
11/13/2008WO2008104183A3 Recombinant anti-epidermal growth factor receptor antibody compositions
11/13/2008WO2008094964A3 Cancer therapy prognosis
11/13/2008WO2008091598A3 CONFORMATION AND ACTIVITY OF Gβ5 COMPLEXES
11/13/2008WO2008089403A3 Oligosaccharides comprising an aminooxy group and conjugates thereof
11/13/2008WO2008085557A3 Alphavirus replicon particles encoding il- 12 as immunological adjuvants
11/13/2008WO2008083331A3 Diagnostic and therapeutic target for autoimmune diseases and uses thereof
11/13/2008WO2008075174A3 Lysosomal associated membrane protein (lamp) - like polypeptide, ligands to the same, and use of the same in the frame of detection and purification of human plasmacytoid dendritic cells
11/13/2008WO2008073615A3 N-glycosylation mutant of melanoma differentiation associated gene-7
11/13/2008WO2008064910A3 Metastasis-specific peptides and their diagnostic and therapeutic applications
11/13/2008WO2008052933A3 Prevention of aggregation of immunoglobulin light or heavy chains
11/13/2008WO2008052111A3 Resistin antagonists and their use
11/13/2008WO2008045437A9 Chimeric t-cell receptors and t-cells targeting egfrviii on tumors
11/13/2008WO2008042024A3 Neuroactive fragments of app
11/13/2008WO2008036761A3 Anti-microbial defensin-related peptides and methods of use
11/13/2008WO2008035210A3 Recombinant hbsag virus-like particles containing polyepitopes of interest, their production and use
1 ... 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 ... 2916